The Management of Depression in Hospital
- 1 June 1965
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 111 (475) , 511-516
- https://doi.org/10.1192/bjp.111.475.511
Abstract
Desipramine (Pertofran) is a metabolite of imipramine (Tofranil) originally isolated by Herrmann, Schindler and Pulver (1959) and found to be identical with the synthetic compound G.35025. Animal experiments (Gillette et al., 1961) suggest a more rapid action for desipramine, and the majority of clinical trials to date confirm this impression for humans (e.g. Kline et al., 1962; Krakowski, 1963). Some controlled trials, however, (Azima et al., 1962; Hollister et al., 1963) fail to establish that desipramine is either faster acting or more effective than imipramine.Keywords
This publication has 17 references indexed in Scilit:
- TREATMENT OF SEVERE DEPRESSION WITH DESIPRAMINE, A METABOLITE OF IMIPRAMINEAmerican Journal of Psychiatry, 1963
- Amitriptyline in Depressive StatesThe British Journal of Psychiatry, 1963
- Evaluation of Desipramine in Depressive StatesThe Journal of New Drugs, 1963
- A Comparative Trial of Imipramine and Phenelzine in the Treatment of DepressionThe British Journal of Psychiatry, 1963
- The clinical application of desmethylimipramine: A new type of antidepressant drugInternational Journal of Neuropharmacology, 1962
- Prognostic Factors in Treatment of Depressive States with ImipramineBMJ, 1962
- Clinical Features of Depression and the Response to Imipramine (“Tofranil”)Journal of Mental Science, 1962
- Isolation from rat brain of a metabolic product, desmethylimipramine, that mediates the antidepressant activity of imipramine (Tofranil)Cellular and Molecular Life Sciences, 1961
- CARDIAC COMPLICATIONS DURING TREATMENT WITH IMIPRAMIN (TOFRANIL)Acta Psychiatrica Scandinavica, 1961
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960